Volume 82 | ESPE2014 | Next issue

ESPE 2014

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

Card image cap
Dublin, Ireland; 18-20 September 2014. Further information

Free Communications

Beta cells

Inappropriately High Rates of Cell Proliferation in Diffuse Congenital Hyperinsulinism are Linked to Nuclear Expression of CDK6
aUniversity of Manchester, Manchester, UK; bCentral Manchester University Hospitals NHS Foundation Trust, Manchester, UK; cUniversity Hospital Dijkzigt, Rotterdam, The Netherlands
hrp0082fc9.1
Characterising the Immunohistochemical Expression of Dipeptidyl Peptidase-4 in Pancreatic Tissue from Patients with Diffuse and Focal Congenital Hyperinsulinism
Developmental Endocrinology Research Group, UCL Institute of Child Health, Great Ormond Street Children’s Hospital NHS Foundation Trust, London, UK
hrp0082fc9.2
In Search for New Monogenic Diabetes Genes: PCBD1
aMax Delbrück Center for Molecular Medicine, Berlin, Germany; bExperimental and Clinical Research Center, Berlin, Germany; cNemours Children’s Clinic, Jacksonville, Florida, USA; dAmplatz Children’s Hospital, University of Minnesota, Minneapolis, Minnesota, USA; eRoyal Alexandra Hospital for Children, Westmead, New South Wales, Australia; fCharité University Medicine, Berlin, Germany; gUniversity Children’s Hospital, Heidelberg, Germany; hUniversity Children’s Hospital, Zürich, Switzerland
hrp0082fc9.3
Clinical Characteristics and Molecular Genetics Analysis of 20 Patients with Neonatal Diabetes Mellitus from a Single Centre of the South-Eastern Region of Turkey
aDepartment of Paediatric Endocrinology, Great Ormond Street Hospital For Children NHS Trust, London, UK; bInstitute of Child Health, University College London, London, UK; cDepartments of Paediatric Endocrinology, Children State Hospital, Diyarbakir, Turkey; dInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK; eDepartment of Medical Biology and Genetics, Dicle University, Diyarbakir, Turkey; fFaculty of Medicine, Princess Anne Hospital, University of Southampton, Southampton, UK
hrp0082fc9.4
Transient Neonatal Diabetes in Adulthood: Metabolic and Neurodevelopmental Outcomes
aDepartment of Paediatric Endocrinology, Gynaecology, and Diabetology, Necker Enfants-Malades Teaching Hospital, Assistance Publique--Hôpitaux de Paris, IMAGINE affiliate, Paris, France; bFaculty of Medi, Paris, France; cINSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France; dDepartment of Endocrinology and Diabetology, Montélimar Hospital, Montélimar, France; eDepartment of Paediatric, Mont de Marsan Hospital, Mont de Marsan, France; fDepartment of Paediatric, Besançon Hospital, Besançon, France; gDepartment of Diabetology, La Pité Salpétrière Teaching Hospital, Assistance Publique--Hôpitaux de Paris, France; hFaculty of Medicine Pierre et Marie Curie, Paris, France; iINSERM_UMRS1138, Centre de Recherche des Cordeliers, Paris, France; jDavid Grant USAF Medical Center, Fairfield, California, USA; kDepartment of Diabetology, Montpellier Teaching Hospital, Montpellier, France; lDepartment of Endocrinology and Diabetology, Cholet Hospital, Cholet, France; mThe Jesse Z and Sara Lea Shafer Institute of Endocrinology and Diabetes, The National Center for Childhood Diabetes, Schneider Children’s Medical Centre of Israel, Petah Tikva, France; nDepartment of Paediatric, Nancy Teaching Hospital, Nancy, France; oDepartment of Paediatrics, Paediatric Teaching Hospital, Toulouse, France; pDepartment of Pediatric, Castres Hospital, Castres, France; qDepartment of Internal Medicine, Robert Bisson Hospital, Lisieux, France; rDepartment of Endocrinology, Roanne Hospital, Roanne, France; sDepartment of Paediatrics, Jeanne de Flandre Teaching Hospital, Lille, France; tDepartment of Paediatric, Children Hospital, Roubaix, France; uDepartment of Genetics, Robert-Debré Teaching Hospital, Assistance Publique--Hôpitaux de Paris, Paris, France; vDepartment of Genetics, La Pité Salpétrière Teaching Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France
hrp0082fc9.5
Sulfonylurea Therapy Corrects Hypotonia, Attention Deficits, Improves Complex Neuropsychological Functions and Motricity in Patients with Neonatal Diabetes Secondary to Mutation in Potassium Channel Subunits, Through a CNS Effect
aService Endocrinologie, Gynécologie et Diabétologie Pédiatrique, Hôpital Universitaire Necker Enfants Malades, Paris, France; bFaculté de Médecine Paris Descartes, Université Sorbonne Paris Cité, Paris, France; cInserm U1016, Institut Cochin, Paris, France; dInserm UMR-S0669, Université Paris Sud et Paris Descartes, Service de Pédopsychiatrie, Paris, France; eCentre de Référence des Canalopathies Musculaires, Hôpital La pitié Salpêtrière, Paris, France; fService d’Ophtalmologie, Hôpital Universitaire Robert Debré, Paris, France; gService d’Ophtalmologie, Hôpital Universitaire Necker Enfants Malades, Paris, France; hService d’Imagerie Médicale, Hôpital Universitaire Necker Enfants Malades, Paris, France; iService de Neurologie Pédiatrique, Hôpital Universitaire Necker Enfants Malades, Paris, France; jService de Génétique, Hôpital Universitaire Robert Debré, Université Denis Diderot, Paris, France; kUnité de Recherche Clinique, Centre d’Investigation Clinique, Hôpital Universitaire Necker Enfants Malades, Paris, France; lService de Pédiatrie, Centre Hospitalier de Versailles, Paris, France; mDépartement de Neurophysiologie Clinique, Université Pierre et Marie Curie, Paris, France
hrp0082fc9.6